Last updated: 16 June 2019 at 9:46pm EST

Robert V Linden Net Worth




The estimated Net Worth of Robert V Linden is at least $699 Tausend dollars as of 5 June 2013. Robert Linden owns over 9,383 units of Lemaitre Vascular Inc stock worth over $565,784 and over the last 17 years Robert sold LMAT stock worth over $133,360.

Robert Linden LMAT stock SEC Form 4 insiders trading

Robert has made over 2 trades of the Lemaitre Vascular Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Robert sold 9,383 units of LMAT stock worth $60,520 on 5 June 2013.

The largest trade Robert's ever made was selling 11,941 units of Lemaitre Vascular Inc stock on 6 May 2013 worth over $72,840. On average, Robert trades about 547 units every 1 days since 2008. As of 5 June 2013 Robert still owns at least 6,522 units of Lemaitre Vascular Inc stock.

You can see the complete history of Robert Linden stock trades at the bottom of the page.



What's Robert Linden's mailing address?

Robert's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Lemaitre Vascular Inc

Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over $169,251,022 worth of Lemaitre Vascular Inc stock and bought 22,755 units worth $292,783 . The most active insiders traders include George W Le Maitre, Guido J Neels und David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,488,890. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth $107,236.



What does Lemaitre Vascular Inc do?

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.



Complete history of Robert Linden stock trades at Lemaitre Vascular Inc

Insider
Trans.
Transaktion
Gesamtpreis
Robert V Linden
Vizepräsident und North American Sales
Verkauf $60,520
5 Jun 2013
Robert V Linden
Vizepräsident und North American Sales
Verkauf $72,840
6 May 2013


Lemaitre Vascular Inc executives and stock owners

Lemaitre Vascular Inc executives and other stock owners filed with the SEC include: